The photobiomodulation study was conducted at the Ludwig Boltzmann Institute for Experimental and Clinical Traumatology in Vienna, Austria, with the aim of comparing and evaluating the effect of LED light at various wavelengths on the healing process in diabetic wounds. The lesions were treated with LED therapy by REPULS at 470 nm (blue), 540 nm (green) 17 or 635 nm (red) at 40mW/cm, while measuring the standardized erythema value (SEV*) and lesion size using Scarletred®Vision. 

As wound care and healing, due to diabetes, but also due to demographic change, pose an increasing challanege in society, monitoring treatment and disease progression also remotely becomes more important than ever. Find out more about implementing Scarletred®Vision in remote wound care and management.

Find the full publication on our homepage.